HTADMIN

Product Recall

Recall of Tetracycline HCl Capsules USP, 250 mg and 500 mg – Click Link below Press Release Tetracycline

Be the First to comment. Read More

Avet Pharma Labs Inc. Announces Acquisition of 23 FDA-Approved ANDAs

East Brunswick, NJ, February 6, 2019 – Avet Pharma Labs Inc. (Avet) today announced that they have acquired a portfolio of 23 abbreviated new drug applications (ANDAs), covering 17 product families, all of which have been previously approved by the U.S. Food and Drug Administration (FDA). Financial terms were not disclosed. Of the newly acquired […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Modafinil Tabs

East Brunswick, NJ, June 1, 2018. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Modafinil 100 and 200mg tablets. This launch adds to Avet’s robust portfolio of generic oral solid products. Modafinil is the AB rated generic equivalent to the wakefulness-promoting drug Provigil®*. It is indicated for the treatment of disorders such as narcolepsy, […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Acyclovir Capsules

East Brunswick, NJ, May 14, 2018. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Acyclovir 200mg Capsules. This launch adds to Avet’s robust portfolio of generic oral solid products. Acyclovir is the AB rated generic equivalent to the antiviral drug Zovirax®. It is indicated for the treatment of herpes zoster, genital herpes and chickenpox. […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Etomidate for Injection

East Brunswick, NJ, May 14, 2018. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Etomidate Injection, USP, in 20mg/10mL and 40mg/20mL strengths. This launch adds to Avet’s growing portfolio of generic injectable products. Etomidate is the AP rated generic equivalent to the general anesthetic drug Amidate™. It is indicated for the induction of general […]

Be the First to comment. Read More

Avet Pharma Announces Executive Leadership Changes

East Brunswick, NJ, April 18, 2018. Avet Pharmaceuticals Inc., an East Brunswick-based specialty generic pharmaceutical company, today announced that industry veteran William S. Marth has joined the Company as President and Chief Executive Officer, North America and Europe, of the Company’s parent, Avet Pharma Holdings Inc. Mr. Marth also will be appointed as a member […]

Be the First to comment. Read More

Avet Pharma Announces the Opening of a New Manufacturing Facility

East Brunswick, NJ, Mar. 22, 2018. Avet Pharmaceuticals Inc. (“Avet”), based in One Tower Center, East Brunswick, New Jersey, is very excited to announce the opening of a new 38,000 square foot production facility located at 16 Elkins Road in East Brunswick, NJ. The new, state-of-the-art manufacturing facility, operated by Avet Pharma Labs Inc. (“Avet […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Losartan Tabs

Eatontown, NJ, March 1 2018. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Losartan Potassium Film Coated immediate-release tablets: 25mg, 50mg, and 100mg. This launch adds to Avet’s robust portfolio of generic oral solid products. Losartan is the AB rated generic equivalent to the anti-hypertensive drug Cozaar®. It is indicated for the treatment of […]

Be the First to comment. Read More

Avet Pharma Moves to New Facility

Located on a 14-acre site, the Tower Center complex is strategically situated directly off the New Jersey Turnpike where Routes 1 and 18 converge. The location offers easy access to Northern New Jersey, New York and Philadelphia by auto, rail and bus. Newark International Airport is within 30 minutes. Download Press Release

Be the First to comment. Read More

Avet Pharma Announces the Launch of Amantadine Capsules

Eatontown, NJ, Sept., 14 2017. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Amantadine immediate-release 100mg capsules. This launch adds to Avet’s robust portfolio of generic oral solid products. Amantadine is the AB rated generic equivalent to the antiviral/antiparkinsonian drug Symmetrel®. It is indicated for the treatment of influenza A virus infection and is […]

Be the First to comment. Read More

Avet Pharma Partners with the Dispensary of Hope

Eatontown, NJ, Sept., 14 2017. Avet Pharmaceuticals Inc. (“Avet”) has partnered with the Dispensary of Hope to provide much needed medications to those affected by Hurricane Harvey. Avet donated over 6,200 units of several important medications, and the Dispensary of Hope will ensure this medication gets to those in need. Download Press Release

Be the First to comment. Read More

Avet Pharma Announces the Launch of Bupropion Tablets

Eatontown, NJ, July, 25 2017. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Bupropion HCl immediate-release 75 and 100mg tablets. This launch adds to Avet’s robust portfolio of generic oral solid products. Bupropion is the AB rated generic equivalent to the antidepressant drug Wellbutrin®. It is indicated for the treatment of depression. According to […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Glycopyrrolate Tablets

Eatontown, NJ, July, 25 2017. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Glycopyrrolate immediate-release 1 and 2mg tablets. This launch adds to Avet’s robust portfolio of generic oral solid products. Glycopyrrolate is the AB rated generic equivalent to the anticholinergic drug Robinul®. It is indicated for adjunctive therapy in the treatment of peptic […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Desipramine Tablets

Eatontown, NJ, June, 12 2017. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Desipramine immediate-release 10, 25, 50, 75, 100 and 150mg tablets. This launch adds to Avet’s robust portfolio of generic oral solid products. Desipramine is the AB rated generic equivalent to the antidepressant drug Norpramin®. It is indicated for the treatment of […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Calcium Acetate 667mg Immediate-Release Tablets

Eatontown, NJ, March, 27 2017. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Calcium Acetate 667mg immediate-release tablets. This launch adds to Avet’s robust portfolio of generic oral solid products. Calcium Acetate is the AB rated generic equivalent to the phosphate binding drug Eliphos®. It is indicated to reduce serum phosphorus in patients with […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Midazolam Injection

Eatontown, NJ, January, 31 2017. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Midazolam Injection in 2mg/2mL, 25mg/5mL and 50mg/10mL strengths. This launch adds to Avet’s growing portfolio of generic injectable products. Midazolam is the AP rated generic equivalent to the anesthetic drug Versed®. It is used as an agent for preoperative sedation. According […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Isosorbide Mononitrate ER 30mg Tablets

Eatontown, NJ, January, 31 2017. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Isosorbide Mononitrate Extended-Release 30mg tablets. This launch adds to Avet’s robust portfolio of generic oral solid products, and is an addition to Avet’s marketed Isosorbide Mononitrate ER 60mg tablets. Isosorbide Mononitrate is the AB rated generic equivalent to the antianginal drug […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Acetazolamide Tablets

Eatontown, NJ, January, 4 2017. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Acetazolamide Immediate-Release 125 and 250mg tablets. This launch adds to Avet’s robust portfolio of generic oral solid products. Acetazolamide is the AB rated generic equivalent to the carbonic anhydrase inhibitor drug Diamox®. It is indicated for the treatment of glaucoma, epilepsy, […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Trospium Tablets

Eatontown, NJ, November, 14 2016.  Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Trospium 20mg tablets.  This launch adds to Avet’s robust portfolio of generic oral solid products. Trospium is the AB rated generic equivalent to the antispasmodic drug Sanctura®.  It is indicated for the treatment of overactive bladder symptoms, such as incontinence, urgency […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Tranexamic Acid for Injection

Eatontown, NJ, October, 19 2016. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Tranexamic Acid Injection, 1,000mg/10mL strength. This launch adds to Avet’s growing portfolio of generic injectable products. Tranexamic Acid is the AP rated generic equivalent to the antifibrinolytic drug Cyklokapron®. It is indicated for short-term use to reduce or prevent hemorrhaging for […]

Be the First to comment. Read More

Avet Provides Non-U.S. Counterfeit BiCNU Notice

Avet Pharmaceuticals Inc. (“Avet”) recently became aware of the existence of a counterfeit drug product labeled as Carmustine for Injection (“BiCNU®”) 100mg that has been sold and distributed outside of the United States. BiCNU® is primarily used for chemotherapy in the treatment of several types of brain cancer (including glioma, glioblastoma multiforme, medulloblastoma and astrocytoma) […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Ethosuximide Soft Gelatin Capsules

Eatontown, NJ, April, 1 2016. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Ethosuximide 250mg soft gelatin capsules. This launch adds to Avet’s robust portfolio of generic oral solid products. Ethosuximide is the AB rated generic equivalent to the antiepileptic drug Zarontin®*. It is indicated for the control of absence (petit mal) epilepsy. According […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Verapamil 40mg

Eatontown, NJ, December 3, 2015. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Verapamil 40mg immediate-release tablets. This launch adds to Avet’s robust portfolio of generic oral solid products, and provides Avet with all three strengths of Verapamil (40, 80 and 120mg). Verapamil is the AB rated generic equivalent to the calcium channel blocker […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Calcium Acetate Capsules

Eatontown, NJ, September, 28 2015. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Calcium Acetate 667mg immediate-release capsules. This launch adds to Avet’s robust portfolio of generic oral solid products. Calcium Acetate is the AB rated generic equivalent to the phosphate binding drug PhosLo®*. It is indicated to reduce serum phosphorus in patients with […]

Be the First to comment. Read More

Avet Pharmaceuticals Initiates a Nationwide Voluntary Recall of Colistimethate for Injection USP, 150 mg and Rifampin for Injection USP, 600 mg/vial Due to a Lack of Sterility Assurance

Eatontown, NJ, February 24, 2015 – Avet Pharmaceuticals Inc. (Avet) today announced the voluntary nationwide recall of ten (10) lots of Colistimethate for Injection, USP, 150 mg Single-Dose vial (NDC 23155-193-31) and three (3) lots of Rifampin for Injection, USP, 600 mg Single-Dose vial (NDC 23155-340-31) manufactured by Emcure Pharmaceuticals Ltd. and distributed by Avet. […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Felodipine Extended-Release Tablets

Eatontown, NJ, December 1, 2014. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Felodipine extended-release tablets in 2.5, 5 and 10 mg strengths. This launch adds to Avet’s robust portfolio of generic oral solid products. Felodipine is the AB rated generic equivalent to the calcium channel blocker drug Plendil®ⱡ. It is indicated for the […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Furosemide for Injection

Eatontown, NJ, December 1, 2014. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Furosemide Injection, USP, in 20mg/2mL, 40mg/4mL and 100mg/10mL strengths. This launch adds to Avet’s growing portfolio of generic injectable products. Furosemide is the AP rated generic equivalent to the diuretic drug Lasix®ⱡ. It is indicated for the treatment of edema. According […]

Be the First to comment. Read More

Avet Announces the Launch of Rizatriptan Immediate Release Tablets

Eatontown, NJ, November 26, 2014. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Rizatriptan immediate-release tablets in 5 and 10 mg strengths. This launch adds to Avet’s robust portfolio of generic oral solid products. Rizatriptan is the AB rated generic equivalent to the anti-migraine drug Maxalt®*. It is indicated for the acute treatment of […]

Be the First to comment. Read More

Avet Pharma Announces the Launch of Rifampin for Injection

Eatontown, NJ, October, 31 2014. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of sterile Rifampin for injection, USP, containing 600mg/vial. This launch adds to Avet’s growing portfolio of generic injectable products. Rifampin is the AP rated generic equivalent to the antibiotic drug Rifadin® IV*. It is indicated for the treatment of all forms of […]

Be the First to comment. Read More

Avet Pharmaceuticals Inc. Signs Exclusive Development Supply & Distribution Agreement with Dexcel Ltd.

Eatontown, NJ, August 5, 2014. Avet Pharmaceuticals Inc. (“Avet”) has signed an Exclusive Development, Supply & Distribution Agreement with Dexcel Ltd. (“Dexcel”) for an Extended Release ANDA drug product. Dexcel will be responsible for the development, registration and manufacturing of the product, and Avet Pharmaceuticals will be responsible for marketing and distribution in the U.S. […]

Be the First to comment. Read More

Avet Pharma Annouces The Launch of Prochlorperazine Injection

Eatontown, NJ, January 16, 2014. Avet Pharmaceuticals Inc. announced the immediate availability of Prochlorperazine Edisylate Injection in the 5mg/mL strength. This product is the AP rated generic equivalent to the former brand Compazine and adds to Avet’s growing portfolio of generic injectable prescription products. According to IMS data for the twelve-months ended December 2013, the […]

Be the First to comment. Read More

Avet Pharmaceuticals Announces Opening of New Corporate Headquarters

Avet Pharmaceuticals Inc. announced relocation into its new corporate headquarters in Eatontown, NJ. The move completes the build out of a new 15,000 square foot corporate office in the Monmouth County, NJ technology corridor and provides Avet with a fresh template for continued growth. Commenting on the move, Avet President and CEO, Jeffrey Glazer, stated, […]

Be the First to comment. Read More

Avet Pharma’s Anne Sather Awarded Cardinal Health Injectable Trade Rep of the Year

Avet Pharmaceuticals Inc. is pleased to congratulate its own Anne Sather, Associate Director, National Accounts on being name Cardinal Health’s Injectable Trade Representation of the Year for 2013! Avet President and CEO, Jeffrey Glazer, stated, “This award embraces Anne’s hard work, dedication and attention to detail that have continued to contribute to Avet’s commercial success. […]

Be the First to comment. Read More

Avet Announces the Return of Tetracycline HCl Capsules

Avet Pharmaceuticals Inc. announced the immediate availability of Tetracycline HCl Capsules, USP in 250 and 500 mg strengths. This product is the AB rated generic equivalent to the antibiotic Achromycin V and adds to Avet’s robust portfolio of generic oral solid products. Tetracycline capsules have been on the FDA drug shortage list for the past […]

Be the First to comment. Read More

Avet Announces the Launch of Acyclovir Tablets

Avet Pharmaceuticals Inc. announced the immediate availability of Acyclovir Tablets in 400mg and 800mg strengths. This product is the AB rated generic equivalent to the brand Zovirax® and adds to Avet’s robust portfolio of generic oral solid products. According to IMS data for the twelve-months ended July 2013, the U.S. market for Acyclovir Tablets approximated […]

Be the First to comment. Read More

Avet Announces Launch of Nifedipine Soft Gel Capsules

Avet Pharmaceuticals Inc. announced the immediate availability of Nifedipine soft gel capsules in 10 and 20 mg strengths. This product is the AB rated generic equivalent to the calcium blocker drug Procardia® and adds to Avet’s robust portfolio of generic oral solid products. According to IMS data for the twelve-months ended May 2013, the U.S. […]

Be the First to comment. Read More

Avet announces launch of Doxycycline Hyclate Delayed Release Tablets

Avet Pharmaceuticals Inc. announced the immediate availability of Doxycycline Hyclate delayed release tablets in 75, 100, and 150 mg strengths. This product is the AB rated generic equivalent to the antibiotic drug Doryx® and adds to Avet’s robust portfolio of high barrier, extended release oral solid products. According to IMS data for the twelve-months ended […]

Be the First to comment. Read More

Avet announces launch of Calcitriol soft gel capsules

Avet Pharmaceuticals Inc. announced the immediate availability of Calcitriol soft gel capsules in 0.25 and 0.5 mcg strengths. This product is the AB rated generic equivalent to the synthetic Vitamin D drug Rocaltrol®* and adds to Avet’s robust portfolio of generic oral soft gel products. According to IMS data for the twelve-months ended April 2013, […]

Be the First to comment. Read More

Avet announces launch of Venlafaxine tablets in multiple strengths

Avet Pharmaceuticals Inc. announced the immediate availability of Venlafaxine tablets in 25, 37.5, 50, 75 and 100 mg strengths. This product is the AB rated generic equivalent to the antidepressant drug Effexor® and adds to Avet’s robust portfolio of generic oral solid products. According to IMS data for the twelve-months ended October 2012, the U.S. […]

Be the First to comment. Read More

Avet announces the launch of 3 generic injectable products

Avet Pharmaceuticals Inc. announced the immediate availability of three new generic injectable pharmaceutical products, including Cidofovir Injection, Colistimethate for Injection, and Ondansetron Injection. These launches serve as a rapid expansion of our growing generic injectable franchise. Download Press Release

Be the First to comment. Read More

Avet changes appearance of Acetazolamide ER Capsules

Avet Pharmaceuticals Inc. is changing the appearance of Acetazolamide Capsules Extended Release 500 mg. Effective immediately the capsules will no longer include the imprint “134” and instead the new imprint will be “HP120”. There are no formulation or any other changes to this product. Download Press Release

Be the First to comment. Read More

Avet Announces Launch of Irinotecan Hydrochloride Injection in Single Dose Vials

Avet Pharmaceuticals Inc. announced the immediate availability of Irinotecan Injection, the generic form of the chemotherapy drug Camptosar®, in two latex free, preservative free single dose vials. The new product launch represents Avet’s first entry into the injectable generic market segment and serves as a lead product for its growing oncology product franchise. According to […]

Be the First to comment. Read More

Avet Introduces Three Generic Products

Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of three new generic pharmaceutical products, including Doxycycline Monohydrate Tablets, Methimazole Tablets and Nystatin Tablets.

Be the First to comment. Read More

Avet Introduces Two New Generic Products

Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of two new generic pharmaceutical products, including Fosinopril- Hydrochlorothiazide Tablets and Acetazolamide Extended Release Capsules.

Be the First to comment. Read More

Avet Introduces Four New Generic Products

Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of four new generic pharmaceutical products, including Glyburide Tablets, Naratriptan Tablets, Carisoprodol+Aspirin Tablets and Verapamil IR Tablets.

Be the First to comment. Read More

Avet Introduces Metformin Tablets.

Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Metformin HCl Tablets in 500, 850 and 1000 mg strengths.

Be the First to comment. Read More

Avet Introduces Indomethacin Capsules.

Avet Pharmaceuticals Inc. announced the immediate availability of Indomethacin Capsules in 25 and 50mg strengths.

Be the First to comment. Read More

Avet Introduces Glipizide-Metformin Tablets

Avet Pharmaceuticals Inc. announced the immediate availability of Glipizide-Metformin Tablets in 2.5/250, 2.5/500 and 5/500 mg strengths.

Be the First to comment. Read More

Avet Introduces Ropinirole Tablets

Avet Pharmaceuticals Inc. announced the immediate availability of Ropinirole Tablets in .25, .5, 1, 2, 3, 4 and 5mg strengths.

Be the First to comment. Read More

Avet Launches Acyclovir Capsules

Avet Pharmaceuticals Inc. announced that it has launched Acyclovir Capsules 200mg

Be the First to comment. Read More